Nyxoah SA (NYXH)
NASDAQ: NYXH · Real-Time Price · USD
0.8715
-0.0164 (-1.85%)
Oct 30, 2026, 4:00 PM EST - Market closed
Nyxoah Employees
Nyxoah had 154 employees as of December 31, 2025. The number of employees decreased by 30 or 16.29% compared to the previous year.
Employees
154
Change (1Y)
-30
Growth (1Y)
-16.29%
Revenue / Employee
$161,023
Profits / Employee
-$713,606
Market Cap
88.27M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 154 | -30 | -16.29% |
| Dec 31, 2024 | 184 | 37 | 25.07% |
| Dec 31, 2023 | 147 | 9 | 6.76% |
| Dec 31, 2022 | 138 | 32 | 29.96% |
| Dec 31, 2021 | 106 | 34 | 47.15% |
| Mar 31, 2021 | 79 | 36 | 84.71% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Outset Medical | 310 |
| Pulmonx | 296 |
| Apyx Medical | 205 |
| Perspective Therapeutics | 166 |
| LENSAR | 150 |
| Owlet | 114 |
| Hyperfine | 102 |
| electroCore | 83 |
NYXH News
- 5 days ago - Nyxoah price target lowered to $3 from $6 at Cantor Fitzgerald - TheFly
- 6 days ago - Nyxoah to Release Third Quarter 2026 Financial Results on November 5, 2026 - GlobeNewsWire
- 13 days ago - Nyxoah reports preliminary Q3 revenue EUR 9.2M, consensus EUR 9.93M - TheFly
- 13 days ago - Nyxoah cuts FY26 revenue view to EUR 33M-EUR 35M from EUR 36M-EUR 40M - TheFly
- 13 days ago - Nyxoah Announces Preliminary Results for the Third Quarter of 2026 and Adjusts Revenue Guidance for 2026 - GlobeNewsWire
- 17 days ago - Nyxoah presents complete ACCCESS U.S. study data, submits PMA supplement to FDA - TheFly
- 4 weeks ago - Nyxoah names Liam Kelly as CEO, succeeding Olivier Taelman - TheFly
- 4 weeks ago - Nyxoah Appoints Liam Kelly as Chief Executive Officer - GlobeNewsWire